Correlation Between Acrivon Therapeutics, and Quoin Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Quoin Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Quoin Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Quoin Pharmaceuticals Ltd, you can compare the effects of market volatilities on Acrivon Therapeutics, and Quoin Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Quoin Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Quoin Pharmaceuticals.
Diversification Opportunities for Acrivon Therapeutics, and Quoin Pharmaceuticals
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Acrivon and Quoin is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Quoin Pharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quoin Pharmaceuticals and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Quoin Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quoin Pharmaceuticals has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Quoin Pharmaceuticals go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and Quoin Pharmaceuticals
Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to generate 0.89 times more return on investment than Quoin Pharmaceuticals. However, Acrivon Therapeutics, Common is 1.12 times less risky than Quoin Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Quoin Pharmaceuticals Ltd is currently generating about -0.05 per unit of risk. If you would invest 1,231 in Acrivon Therapeutics, Common on August 31, 2024 and sell it today you would lose (473.00) from holding Acrivon Therapeutics, Common or give up 38.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.73% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. Quoin Pharmaceuticals Ltd
Performance |
| Timeline |
| Acrivon Therapeutics, |
| Quoin Pharmaceuticals |
Acrivon Therapeutics, and Quoin Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and Quoin Pharmaceuticals
The main advantage of trading using opposite Acrivon Therapeutics, and Quoin Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Quoin Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quoin Pharmaceuticals will offset losses from the drop in Quoin Pharmaceuticals' long position.| Acrivon Therapeutics, vs. Aerovate Therapeutics | Acrivon Therapeutics, vs. Adagene | Acrivon Therapeutics, vs. Rezolute | Acrivon Therapeutics, vs. AN2 Therapeutics |
| Quoin Pharmaceuticals vs. Revelation Biosciences | Quoin Pharmaceuticals vs. Virax Biolabs Group | Quoin Pharmaceuticals vs. Neurobo Pharmaceuticals | Quoin Pharmaceuticals vs. Allarity Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |